New Delhi: The Foreign Direct Investment (FDI) into the hospital and diagnostic centres sector in the country has witnessed a decline of 5.9 per cent during the first three months of the current fiscal year, while the foreign equity infusion into the medical and surgical appliances sector declined by 1.7 per cent during the same period.
The hospital and diagnostic centres in the country has attracted a foreign fund infusion of $154.83 million during the April to June quarter of 2023, as compared to $164.47 million during the same period of previous year.
The cumulative foreign equity investment into the sector stood at $8.89 billion from April, in the year 2000 to June, 2023. The cumulative investments from April, 2000 to June, 2022 was $8.09 billion, which indicates that the sector has reported an FDI inflow of around $800 million in a year from June, 2022 to the same month of 2023.
As reported earlier, the FDI infusion into the sector has registered a growth of 16.2 per cent during the fiscal year 2022-23, at $810 million fund infusion, as compared to $697 million inflow reported in 2021-22. The cumulative FDI equity inflow into the sector stood at $8.73 billion from April, 2000 to the end of March, 2023, growing from $7.92 billion reported at the end of March, 2022.
The medical and surgical appliances sector registered a decline of 1.7 per cent in FDI infusion during the three months from April to June, 2023, at $300.03 million as compared to $305.35 million during the same period of previous fiscal year.
The cumulative FDI infusion into the sector from April, 2000 to June, 2023, according to the data from the ministry of commerce and industry, is at $3.10 billion, as compared to $2.71 billion reported from April, 2000 to June, 2022.
The sector has seen the FDI equity inflow almost doubling during the fiscal year 2023. The foreign investment into the sector stood at $397 million during the fiscal year, as compared to $208 million in the 12 months of previous fiscal year. The cumulative foreign investment flow from April, 2000 to March, 2023 stood at $2.80 billion, while till March, 2022, it was $2.19 billion, according to the data.
As reported earlier, the FDI equity inflow into the pharmaceutical sector has reported a decline of 82 per cent in the first three months of the current fiscal year, as compared to the same period of previous year.
The decline comes after a significant growth of 45 per cent reported for the 12 month ended March, 2023, according to official data.
The FDI investments into the drugs and pharmaceuticals sector during the first quarter ended June, 2023, stood at $90 million, as compared to $497 million reported during April to June, 2022, which was almost a three-fold growth from the $130 million FDI equity inflow reported during April to June, 2021.
The equity inflow in April to June, 2023 quarter was also a decline of 62.5 per cent compared to the $240 million inflow reported in the sequential quarter of January to March, 2023.
The cumulative FDI inflow from April 2000 to June, 2023, stood at $21.55 billion, remaining in the eight position among the sectors attracting highest FDI equity inflow in the country, which is led by the services sector at $105.4 billion.
